Skip to main content

5 CTMS Metrics that Result in Better Trials

Still running trials on a legacy CTMS? Limited visibility into five key metrics makes it tougher to catch delays and bottlenecks before they become problems.

Modern Clinical Trial Management Systems are a breath of fresh air for the CRO industry. Surveys conducted by Tata Consulting found that of 211 CXOs polled, over 66% used legacy applications. 70% of global CXOs see software modernization as a top priority. And it makes sense: in a dynamic marketplace, you have to stay ahead of the curve to succeed and expand. 

What does this mean for your team? Every trial must be standardized, optimized, and seamless from startup to completion.

If you’re still working with a legacy CTMS, it can be tough to see where trial performance is slipping. The numbers are there, but they’re delayed or scattered or otherwise hard to interpret. By the time you’ve started noticing issues, timelines have already taken a hit. 

A modern CTMS platform changes that by bringing the right clinical trial metrics into daily workflows. This allows your team to track progress as it happens instead of seeing the consequences weeks later in a report. When metrics are visible and easy to act on, studies move faster and with fewer surprises. 

Let’s look at the metrics that have the biggest impact on trial outcomes and what improves when they’re consistently tracked. 

1) Enrollment

Enrollment is one of the most closely watched clinical trial KPIs, but it’s often one of the hardest to manage in real time with a legacy system. Teams end up relying on manual updates, outdated spreadsheets, scattered email threads, or delayed site reports. That kind of lag creates uncertainty around forecasting and makes it difficult to intervene early when performance drops. 

A modern CTMS system centralizes enrollment data across all sites, updating continuously as new subjects are screened and randomized. This supports study managers in comparing planned versus actual enrollment at a single glance. They can filter by geography and identify trends across similar site types and demographics. 

This level of visibility supports several practical courses of action. Better control over patient enrollment metrics leads to fewer surprises and more predictable timelines. Your team can reallocate recruitment budgets towards higher performing sites and adjust clinical trial enrollment projections with greater accuracy. Visible enrollment metrics also allow for more informed conversations with sponsors and stakeholders as you can discuss real-time data rather than estimates. 

2) Site Activation Times

Study startup includes multiple parallel processes, each with its own dependencies and departments. Contracts, regulatory approvals, feasibility assessments, and training must all be completed before a site can start enrolling patients. In a legacy system, these steps are often tracked in isolation. This makes it hard to understand where delays are coming from and how to prevent them. 

Tracking site activation metrics offers a clear view into the full clinical trial startup timeline. By measuring the time between key milestones, teams can pinpoint where time is being lost. Site selection, contract execution, ethics approval, and site initiation are all possible causes and the key is being able to differentiate between their data results. 

A modern CTMS system connects these milestones directly to each site record. Study teams can compare activation timelines across sites, countries, and partners, making patterns easier to spot. Shortening activation timelines has a direct downstream effect: sites start enrolling sooner, overall study duration decreases, and resources are used more efficiently across the startup phase. 

3) Monitoring Visit Frequency

Monitoring plays a central role in maintaining study quality, but traditional approaches often rely on fixed schedules and don’t reflect actual site performance. This can lead to inefficiencies, where low-risk sites receive the same level of attention as high risk ones. Tracking monitoring visit frequency metrics alongside operational data introduces a more informed approach to oversight. A modern CTMS platform connects monitoring activity with key indicators like enrollment pace and site responsiveness. 

When these data points are viewed together, your team can adjust monitoring plans based on actual need. Sites with stable performance and low issue rates might require fewer visits, while sites showing signs of struggle can receive more frequent attention. This approach supports better allocation of CRA time and reduces unnecessary travel and administrative work. It also improves consistency in oversight by focusing attention where it has the greatest impact on study quality. 

4) Protocol Deviation Trends

Protocol deviations are a common challenge in clinical trials, but the timing of when they’re reviewed often limits their usefulness. In many cases, deviations are only analyzed after they’ve accumulated. This makes it harder to correct underlying issues. 

Tracking clinical trial protocol deviation trends in real time provides a more proactive approach. When deviations are recorded within a modern CTMS, they can be categorized and linked to specific sites, visits, or procedures. This allows study teams to identify patterns as they develop, whether it’s a rise in deviations that indicates a training gap or repeated deviations tied to a specific procedure that suggests that protocol instructions need clarification. 

With early visibility, your team can take targeted action, like retraining site staff with updated documents or increasing monitoring at affected sites. Over time, this reduces the overall number of deviations and supports stronger inspection readiness. 

5) Query Resolution Time

Data queries are an unavoidable part of clinical trials and slow resolution times can create significant downstream delays. When queries stay open for extended periods, it pushes back database locks and affects timelines for analysis and submission. 

Tracking query resolution time helps show how quickly issues are identified and addressed. In a legacy environment, this information’s often difficult to compile and requires manual tracking across systems. 

A modern clinical trial software platform captures every query activity in real time. It links each query to its site, subject, and status. Study teams can monitor average resolution times, identifying sites with recurring delays and tracking the age of open queries. 

Having this data supports more focused follow-up. Your team can prioritize sites with longer resolution times for outreach and address recurring issues through additional training or process adjustments. As you build data history, faster query resolution contributes to cleaner data and shorter timelines for database lock. 

The Advantages of a Unified Metric Source

The real value of these metrics comes from having them all in one place. While legacy systems often require teams to piece together data from multiple tools, a modern CTMS connects enrollment, startup progress, monitoring activity, and query data into one consistent view. 

There’s no more duplicate data entry or waiting for reports to be built or confusion over which numbers are correct. Instead, teams work from a shared, up-to-date view of the study at all times. This improves coordination across functions and reduces time spent verifying data. It also improves communication across departments by grounding decisions in clear, reliable data.

In today’s dynamic marketplace, having data isn’t enough: it must be the right data at the right time. Better metrics lead to better trials, from start date to conclusion.

Key Takeaways:

  • Enrollment metrics improve forecasting and reduce delays. 
  • Site activation metrics shorten startup timelines and show bottlenecks. 
  • Monitoring visit frequency supports more efficient and targeted oversight. 
  • Protocol deviation trends help identify and correct issues before they become problematic.
  • Query resolution time reduces data delays and supports faster database lock. 
  • A modern CTMS platform centralizes all clinical trial KPIs for clearer, more effective decision-making. 

Looking for the best move for your team? Switch to the BSI CTMS.

The BSI CTMS is the best CTMS solution on the block and we have the track record to prove it. Our modern CTMS solutions cover all aspects of your large enterprise clinical trials and we want you to test them for your team!

BSI’s CTMS is the most innovative, function-complete, and easy-to-use clinical trial management software on the market. It provides CTMS, eTMF, Study Startup and Trial Supply Management in one integrated, unified platform.

Standard interfaces (API) assure complete data oversight and easy integration with the external systems (e.g. EDC and eTMF) of your choice. The BSI CTMS is the central hub for all aspects of your clinical trials. It’s available as SaaS for ease of use, continuous improvement, and simplified infrastructure.

We’re modern, sleek, and designed with the user in mind for intuitive end-to-end clinical trial management. And the best part? We offer updates, upgrades, and scalability in-house with a full client support team for your legacy system migration and beyond. 

There’s never been a better time to switch to a better CTMS. Book a call today! 

Your Next Step:

BSI Life Sciences

 

LET'S TALK

Jakub Surina
Global Head of Business Development

+41 58 255 94 30
jakub.surina@bsi-software.com